New Protocol: subQ daratumumab + CyBorD in light chain amyloidosis
|New Protocol: subQ daratumumab + CyBorD in light chain amyloidosis|
• Open-label, randomized phase III trial (ANDROMEDA)
Not published as of Feb 6, 2021. Based on package insert
Reviewed by Ulas Darda Bayraktar, MD on Feb 6, 2021
Altai Chemo Planner
Quickly Prepare Accurate Chemotherapy Orders
Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.